Navigation Links
Biocoat and Agion to Develop and Co-market Coatings for Medical Devices.
Date:4/4/2009

Biocoat, Inc., maker of lubricious HYDAK® hydrophilic coatings, and Agion Technologies, the worldwide leader in natural silver-based antimicrobial solutions, today announced a co-marketing agreement to develop and promote a coatings product line featuring Agion's antimicrobial protection for medical devices.

Horsham, PA (PRWEB) April 4, 2009 -- Biocoat, Inc., maker of lubricious HYDAK® hydrophilic coatings, and Agion Technologies, the worldwide leader in natural silver-based antimicrobial solutions, today announced a co-marketing agreement to develop and promote a coatings product line featuring Agion's antimicrobial protection for medical devices.

This agreement utilizes technology co-owned and patented by Agion and Biocoat for hyaluronan coatings that incorporate silver-based antimicrobial properties. Coatings that take advantage of this synergistic combination of non-thrombogenicity and antimicrobial properties are now available to device makers for immediate evaluation in their products.

"We believe that Agion's silver zeolite technology and the unique properties of coatings based on hyaluronic acid will be a major advance in medical coatings," said Djoerd Hoekstra, CEO of Biocoat. Dr. Josh Simon, Senior Product Manager for Coating Technologies adds, "This is an exciting development not only because it allows us to produce a lubricious coating with antimicrobial properties, but also because of the market timing and prospects for further development of advanced medical coatings."

"Medical devices that incorporate Agion's natural antimicrobial technology actively inhibit the growth of microbes on the device's surface for the life of the product," said Paul Ford, CEO of Agion Technologies. "This partnership will allow us to extend our antimicrobial protection to medical devices that choose Biocoat as their coatings provider."

Coatings that release silver are used on catheters, particularly central venous and urological catheters, where they have been shown to reduce the amount of microbes found on their surfaces. Recently, Medicare declared it will no longer reimburse hospitals for the treatment of some preventable conditions. This is a strong incentive for companies to develop antimicrobial protected devices for prophylactic and therapeutic use.

Biocoat's HYDAK product line of lubricious hydrophilic coatings are based on hyaluronic acid, which occurs naturally in the body and has non-thrombogenic properties. The hyaluronic acid in the coating can be crosslinked or non-crosslinked on a surface to varying degrees in order to control durability in applications where abrasion may occur.

The cornerstone of Agion technology is silver, a naturally occurring and highly effective antimicrobial agent. Silver has long been known for its antimicrobial properties and Agion's zeolite carrier provides many benefits over other antimicrobials that are alcohol-, chlorine-, or ammonium-based. Silver is proven to be safe with no toxic affects on people, plants or animals. Agion technology operates at the surface of a product through the controlled release of silver ions
which attack microbes and inhibit their growth in three different ways. They offer a variety of silver-based technologies to suit various manufacturing and product requirements.

About Biocoat, Inc.:
Biocoat, Inc., a leader in providing hydrophilic coating technology to medical device companies, is a privately-held corporation with administrative offices, manufacturing, and R&D labs in Horsham, PA. Biocoat develops practical applications of its technologies in partnership with established medical device companies, who license HYDAK and other coatings technologies from Biocoat.

For more information about Biocoat, visit www.biocoat.com. For information on hydrophilic coatings, check out the Hydrophilic Coatings Blog at blog.biocoat.org.

About Agion Technologies, Inc.:
Agion Technologies, located in Wakefield, Massachusetts, is a leader in providing customized, natural, antimicrobial solutions based on silver that continuously inhibits the growth of bacteria, mold and fungus. Agion's antimicrobial technology is used in consumer, industrial and healthcare industries and has been incorporated into a variety of products including cell phones, shoes, keyboards, water filters, medical catheters, and ice machines. Agion's customers include many leading brands such as Motorola, PPG, Carrier, DuPont, Adidas, Scotsman, Stanley Bostitch and Oster. For more information about Agion Technologies, visit www.agion-tech.com.

###

Read the full story at http://www.prweb.com/releases/2009/04/prweb2294214.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Markel Expands Classes for Contagion Risk with OUTBREAK(R) Extra Expense Coverage
2. Scientists Develop Natural Protection for Stored Foods
3. Isolation of a new gene family essential for early development
4. AASM encourages those student-athletes at risk for developing osa to visit a sleep clinic
5. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
6. Smokers More Likely to Develop Dementia
7. The Philadelphia Walk Now for Autism Expected to Draw 10,000 Walkers and Raise $1 Million to Help Find Answers About the Nations Fastest-Growing Developmental Disorder
8. Ovation further advances development pipeline with new phase III epilepsy study
9. Researchers develop long-lasting growth hormone
10. Pioneer Surgical Technology Hires Vice President of New Business Development
11. Purdue researchers develop technology to detect cancer by scanning surface veins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... ... the adoption of e-prescribing as measured in Part D Medicare data. The dataset, ... to pharmacies, either using e-prescribing, faxes or paper. The PaPR (pronounced "paper") ...
(Date:4/26/2017)... ... 2017 , ... Infertility may be a result of an ... many women become pregnant upon treating their diagnosis. , To properly ... We can provide the necessary information to diagnose and treat your problem. ...
(Date:4/26/2017)... ... 26, 2017 , ... New SUPRO® XT55 Isolated Soy ... by helping beverage manufacturers more effectively manage protein costs. “Soy protein has always ... well as more stable pricing over time. Now it’s even more relevant as ...
(Date:4/25/2017)... ... April 25, 2017 , ... Splashtop Inc. , ... . This new addition to the Mirroring360 product family combines device screen mirroring ... Mirroring360 Pro enables educators, business professionals and individuals to stream or mirror app ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... CEOs, CFOs and HR decision-makers are preparing for how his administration could impact ... will provide insight into what changes are most likely to make it through ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017 Cardiology devices segment is anticipated to reach ... The Cardiology Devices segment is likely to create absolute $ ... 2018 over 2017. By the end of 2027, Cardiology Devices ... US$ 700 Mn, expanding at a CAGR of 18.4% over ... Asia Pacific reprocessed medical devices market in ...
(Date:4/19/2017)... , Tenn. and DALLAS , April ... EndoStim, Inc., announced that the first patients in ... the EndoStim device in the Lower Esophageal Sphincter Stimulation ... a minimally-invasive implantable device designed to provide long-term reflux ... neurostimulation. GERD affects nearly 65 million people ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
Breaking Medicine Technology: